Notably, MTF2 was expressed lowly in breast cancer tissue samples at different clinical stages, with a decreasing trend towards the higher stages of the disease, suggesting its role in cancer initiation and progression [17]. This evidence concerns the gene MTF2 and breast carcinoma.